Literature DB >> 26123846

Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.

Ali Esmaeeli-Nadimi1, Derek Kennedy2, Mohammad Allahtavakoli3.   

Abstract

It has been reported that ischemic postconditioning (PC) changes the reperfusion pattern in permanent or transient models of stroke and confers neuroprotection. However, the effects of PC and subsequent use of tissue plasminogen activator (tPA) for the treatment of embolic stroke have not yet been investigated. Rats were subjected to stroke by injection of a preformed clot into the middle cerebral artery and randomly assigned to vehicle (saline 0.1 ml/100 g), tPA (3 mg/kg), PC only or PC+tPA (3 mg/kg). tPA was injected at 6 h after embolic stroke and PC was conducted at 6.5 h after ischemia by using five cycles of a 10 s occlusion and 30 s of reopening of the bilateral common carotid arteries. Cerebral blood flow (CBF) was monitored for 60 min from the time of tPA injection. Infarct size, blood brain barrier disruption, edema, neurological deficits, reactive oxygen species and apoptosis were measured 2 days later. PC decreased infarct volume, but PC+tPA was more neuroprotective than PC alone. While tPA alone dramatically increased CBF, conducting PC caused a gradual increase in CBF. A combination of PC+tPA reduced BBB leakage, brain edema, apoptosis and reactive oxygen species levels. Furthermore, a combination of PC+tPA improved neurological functions at 48 h after the induced stroke. In conclusion, PC hampered malignant hyperemia after reperfusion with tPA and extended its therapeutic window up to 6 h. Compared to PC alone, combination of thrombolysis and PC showed a better neuroprotection.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Embolic stroke; Hyperemia; Ischemic postconditioning; Reperfusion injury; tPA

Mesh:

Substances:

Year:  2015        PMID: 26123846     DOI: 10.1016/j.ejphar.2015.06.043

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Current advances in ischemic stroke research and therapies.

Authors:  Derek Barthels; Hiranmoy Das
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-15       Impact factor: 5.187

Review 2.  Advances in intervention methods and brain protection mechanisms of in situ and remote ischemic postconditioning.

Authors:  Jian-Hui Guo; Li-Yan Li; Chun-Yan Li; Wei Ma; Kuang-Pin Liu; Jin-Wei Yang; Xian-Bin Wang; Zhen Wu; Tong Zhang; Jia-Wei Wang; Wei Liu; Jie Liu; Yu Liang; Xing-Kui Zhang; Jun-Jun Li
Journal:  Metab Brain Dis       Date:  2020-10-12       Impact factor: 3.584

3.  The underlying mechanisms involved in the protective effects of ischemic postconditioning.

Authors:  Rong Xie; Jinquan Li; Heng Zhao
Journal:  Cond Med       Date:  2018

Review 4.  Perioperative stroke: A perspective on challenges and opportunities for experimental treatment and diagnostic strategies.

Authors:  Xia Jin; Peiying Li; Dominik Michalski; Shen Li; Yueman Zhang; Jukka Jolkkonen; Lili Cui; Nadine Didwischus; Wei Xuan; Johannes Boltze
Journal:  CNS Neurosci Ther       Date:  2022-02-27       Impact factor: 5.243

5.  PARK2-dependent mitophagy induced by acidic postconditioning protects against focal cerebral ischemia and extends the reperfusion window.

Authors:  Zhe Shen; Yanrong Zheng; Jiaying Wu; Ying Chen; Xiaoli Wu; Yiting Zhou; Yang Yuan; Shousheng Lu; Lei Jiang; Zhenghong Qin; Zhong Chen; Weiwei Hu; Xiangnan Zhang
Journal:  Autophagy       Date:  2017-01-19       Impact factor: 16.016

6.  TRPV1 receptor-mediated expression of Toll-like receptors 2 and 4 following permanent middle cerebral artery occlusion in rats.

Authors:  Elham Hakimizadeh; Ali Shamsizadeh; Ali Roohbakhsh; Mohammad Kazemi Arababadi; Mohammad Reza Hajizadeh; Mehdi Shariati; Iman Fatemi; Amir Moghadam-Ahmadi; Gholamreza Bazmandegan; Hossein Rezazadeh; Mohammad Allahtavakoli
Journal:  Iran J Basic Med Sci       Date:  2017-08       Impact factor: 2.699

7.  rt-PA with remote ischemic postconditioning for acute ischemic stroke.

Authors:  Ruiwen Che; Wenbo Zhao; Qingfeng Ma; Fang Jiang; Longfei Wu; Zhipeng Yu; Qian Zhang; Kai Dong; Haiqing Song; Xiaoqin Huang; Xunming Ji
Journal:  Ann Clin Transl Neurol       Date:  2019-01-16       Impact factor: 4.511

Review 8.  Development and Testing of Thrombolytics in Stroke.

Authors:  Dmitri Nikitin; Seungbum Choi; Jan Mican; Martin Toul; Wi-Sun Ryu; Jiri Damborsky; Robert Mikulik; Dong-Eog Kim
Journal:  J Stroke       Date:  2021-01-31       Impact factor: 6.967

9.  Ischemic post-conditioning is neuroprotective even at delayed tPA administration after embolic stroke in female rats.

Authors:  Mohadeseh Mohammadi; Masoud Mobini; Fatemeh Mashayekhi; Mohammad Allahtavakoli; Ayat Kaeidi; Jalal Hassanshahi; Ali Shamsizadeh; Elham Hakimizadeh; Mahsa Hassanipour
Journal:  Iran J Basic Med Sci       Date:  2021-12       Impact factor: 2.699

10.  Ischemic postconditioning confers cerebroprotection by stabilizing VDACs after brain ischemia.

Authors:  Gui-Ying Yao; Qian Zhu; Jing Xia; Feng-Jiao Chen; Ming Huang; Jing Liu; Ting-Ting Zhou; Jian-Feng Wei; Gui-Yun Cui; Kui-Yang Zheng; Xiao-Yu Hou
Journal:  Cell Death Dis       Date:  2018-10-10       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.